KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Other Non-Current Liabilities (2016 - 2026)

Exelixis (EXEL) has 17 years of Other Non-Current Liabilities data on record, last reported at $104.4 million in Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities fell 4.11% year-over-year to $104.4 million; the TTM value through Jan 2026 reached $104.4 million, down 4.11%, while the annual FY2026 figure was $104.4 million, 4.11% down from the prior year.
  • Other Non-Current Liabilities reached $104.4 million in Q1 2026 per EXEL's latest filing, down from $112.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $128.6 million in Q3 2025 and bottomed at $1.9 million in Q3 2022.
  • Average Other Non-Current Liabilities over 5 years is $79.9 million, with a median of $95.1 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: crashed 53.35% in 2022, then soared 3129.35% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $68.5 million in 2022, then surged by 37.49% to $94.2 million in 2023, then rose by 1.95% to $96.1 million in 2024, then rose by 17.22% to $112.6 million in 2025, then fell by 7.27% to $104.4 million in 2026.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $104.4 million in Q1 2026, $112.6 million in Q4 2025, and $128.6 million in Q3 2025.